Health

Health
The U.S. will pay Moderna $176 million to develop an mRNA pandemic flu vaccine
The funds are targeted for release through the U.S. Department of Health and Human Services and will pay for continued development of a vaccine that uses the same mRNA technology that allowed rapid development and rollout of vaccines to protect against COVID-19.
Rapamycin may slow aging. Here's one way the drug will be tested
Longevity researchers are taking a generic drug they think may help extend people's lives. Now a dentist is testing if rapamycin stops gum disease — a canary in the coal mine for age-related diseases.
Travelers beware: It’s a big year for dengue
The Centers for Disease Control and Prevention warns of an increased risk of dengue infections in the U.S. this summer. The mosquito-borne virus is surging, and human travel is expanding its reach.
 Floodwaters and bird flu continue to rise in Minnesota, COVID remains low
Flood waters continue to rise in Minnesota rivers. In addition to the immediate danger presented by rising and rushing waters, floods also pose other health risks. Floodwater can contain downed power lines, human and livestock waste, other hazardous waste, and other debris that may not be visible.
Health insurers cover fewer drugs and make them harder to get
Insurance companies are covering fewer drugs than they used to, and patients have to jump through more hoops to get many of them. When shopping for insurance, check for coverage of the drugs you need.
The high cost of medical whistleblowing
MPR News guest host Euan Kerr talks with University of Minnesota bioethicist Carl Elliott about his new book, “The Occasional Human Sacrifice: Medical Experimentation and the Price of Saying No.”